It is estimated that 38,000 Australians each year require radiotherapy, either alone or in combination with other treatments such as surgery or chemotherapy.
The Trans Tasman Radiation Oncology Group (TROG) carries out investigator-driven research in oncology, primarily clinical trials involving radiation therapy designed to improve the outcomes of cancer treatment. Cancers studied by TROG include breast, rectum, prostate, oesophagus, lung, bladder, lymphoma, anal canal, melanoma, brain tumours and bone and liver metastases.
TROG endorses a collaborative approach to clinical trials and, if possible, (dependent on the area of research) works with the other Australasian and international cancer trials groups such as the European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Insititute of Canada (NCIC). TROG has often undertaken the lead role in the design and management of collaborative trials.
There are currently 19 trials underway at TROG using radiotherapy in combination with surgery or chemotherapy.
Click here for an up-to-date list of TROG's research projects.